In an earlier study, the authors found that severely motion sick indiv
iduals could be greatly relieved of their symptoms by intramuscular in
jections of promethazine (50 mg) or scopolamine (.5 mg).(1) Comparable
50-mg injections of promethazine also have been found effective in al
leviating symptoms of space motion sickness.(2) The concern has risen,
however, that such drugs may delay or retard the acquisition of adapt
ation to stressful environments. In the current study, we controlled a
rousal using a mental arithmetic task and precisely equated the exposu
re history (number of head movements during rotation) of a placebo, co
ntrol group and an experimental group who had received promethazine. N
o differences in total adaptation or in rates of adaptation were prese
nt between the two groups. Another experimental group also received pr
omethazine and was allowed to make as many head movements as they coul
d, before reaching nausea, up to 800. This group showed a greater leve
l of adaptation than the placebo group. These results suggest a strate
gy for dealing with space motion sickness that is described.